Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
It is traditionally believed that men and women experience angina—the pain associated with coronary artery disease—in different ways, with men feeling it in their chest and women feeling it in their arms and back.
PathAI, a Boston-based healthcare technology company, has found that AI can help specialists quantify PD-L1 expression on both tumor cells and immune cells.
Cancer Research UK, one of the world’s largest charities focused on improving cancer treatments, has launched a new research network focused on advanced radiotherapy techniques, immunotherapies and AI.
Numerous healthcare providers and technology companies are working together on a new research project focused on using AI to improve care for patients with subarachnoid hemorrhages and diabetes.
Healthcare technology is constantly changing, something radiologists know all too well. And while some within the specialty have expressed fear or concern over the continued rise of AI, a new commentary in Clinical Radiology noted that it’s all par for the course—and radiologists must rise to the occasion yet again.
CMS announced Thursday, Oct. 31, that 25 participants have advanced in the agency’s Artificial Intelligence Health Outcomes Challenge, putting them one step closer to earning $1 million in prize money.
Fifty-three percent of physicians say they are optimistic about AI’s potential effect on healthcare, according to a new survey of more than 1,700 physicians published by the Doctors Company.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
